Silverback Therapeutics Inc at SVB Leerink Global Healthcare (Virtual) Transcript
Hello, everyone. Welcome to the first post-launch for East Coast people -- session at our Global Healthcare Conference. My name is Daina Graybosch. I'm the immuno-oncology analyst here. And I am excited to welcome the management team from Silverback Therapeutics: Laura, Valerie, and Jonathan.
(Conference Instructions)
And with that, maybe I'll turn over to Laura first question, a very high level. If you could just spend a couple of minutes on what is Silverback for people who don't know your story deeply, and then we'll get more into the specific programs and platforms.
Sure. Great, Daina. Thanks for the opportunity to tell the Silverback story. So Silverback is a platform company focused on ImmunoTAC platform, which is the opportunity to mix and match different antibodies with linker-payloads. And, of course, these antibody drug conjugates, as they're typically called, are very popular these days.
For Silverback, our antibody drug
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |